Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China

BACKGROUND: Prospective studies examining long‐term therapeutic outcomes of the Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) regimen in human immunodeficiency virus (HIV) infection remain limited. This study assessed the actual efficacy and safety of BIC/FTC/TAF in HIV‐infected indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Linghong, Xie, Xiaoxin, Fu, Yanhua, Gan, Lin, Yang, Xiaoyan, Ma, Shujing, Long, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461416/
https://www.ncbi.nlm.nih.gov/pubmed/37647435
http://dx.doi.org/10.1002/iid3.974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461416/
https://www.ncbi.nlm.nih.gov/pubmed/37647435
http://dx.doi.org/10.1002/iid3.974

Ejemplares similares